JP2007506699A - 良性前立腺肥大の治療のためのビタミンｄ３アナログの使用 - Google Patents

良性前立腺肥大の治療のためのビタミンｄ３アナログの使用 Download PDF

Info

Publication number
JP2007506699A
JP2007506699A JP2006527365A JP2006527365A JP2007506699A JP 2007506699 A JP2007506699 A JP 2007506699A JP 2006527365 A JP2006527365 A JP 2006527365A JP 2006527365 A JP2006527365 A JP 2006527365A JP 2007506699 A JP2007506699 A JP 2007506699A
Authority
JP
Japan
Prior art keywords
treatment
bishomo
epi
diene
fluoro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
JP2006527365A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007506699A5 (https=
Inventor
アドリニ ルシアノ
コルリ エンリコ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bioxell SpA
Original Assignee
Bioxell SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0322395A external-priority patent/GB0322395D0/en
Priority claimed from GB0325598A external-priority patent/GB2407499B/en
Priority claimed from GB0416876A external-priority patent/GB0416876D0/en
Application filed by Bioxell SpA filed Critical Bioxell SpA
Publication of JP2007506699A publication Critical patent/JP2007506699A/ja
Publication of JP2007506699A5 publication Critical patent/JP2007506699A5/ja
Abandoned legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/04—Drugs for disorders of the urinary system for urolithiasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
JP2006527365A 2003-09-24 2004-09-24 良性前立腺肥大の治療のためのビタミンｄ３アナログの使用 Abandoned JP2007506699A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0322395A GB0322395D0 (en) 2003-09-24 2003-09-24 Methods for treating bladder dysfunction and related compounds and compositions
GB0325598A GB2407499B (en) 2003-11-03 2003-11-03 Vitamin D3 analogue for use in the treatment of BPH
GB0416876A GB0416876D0 (en) 2004-07-29 2004-07-29 Compound and use in treatment
PCT/EP2004/010760 WO2005027923A1 (en) 2003-09-24 2004-09-24 Use of vitamin d3 analogue for the treatment of benign prostatic hyperplasia

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2008209429A Division JP2009035559A (ja) 2003-09-24 2008-08-18 良性前立腺肥大の治療のためのビタミンｄ３アナログの使用

Publications (2)

Publication Number Publication Date
JP2007506699A true JP2007506699A (ja) 2007-03-22
JP2007506699A5 JP2007506699A5 (https=) 2007-10-25

Family

ID=34229055

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2006527365A Abandoned JP2007506699A (ja) 2003-09-24 2004-09-24 良性前立腺肥大の治療のためのビタミンｄ３アナログの使用
JP2008209429A Abandoned JP2009035559A (ja) 2003-09-24 2008-08-18 良性前立腺肥大の治療のためのビタミンｄ３アナログの使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2008209429A Abandoned JP2009035559A (ja) 2003-09-24 2008-08-18 良性前立腺肥大の治療のためのビタミンｄ３アナログの使用

Country Status (11)

Country Link
EP (1) EP1673096A1 (https=)
JP (2) JP2007506699A (https=)
CN (1) CN100488511C (https=)
BE (1) BE1016292A3 (https=)
BR (1) BRPI0404050A (https=)
CH (1) CH698144B1 (https=)
EA (1) EA010240B1 (https=)
FR (1) FR2859910B1 (https=)
NL (1) NL1027109C2 (https=)
NZ (1) NZ535531A (https=)
WO (1) WO2005027923A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090227651A1 (en) * 2004-10-05 2009-09-10 Kissei Pharmaceutical Co., Ltd. Preventive and/or therapeutic agent for urine collection disorder accompanying lower urinary tract obstruction
PL1806136T3 (pl) * 2004-10-06 2012-04-30 Kissei Pharmaceutical Kompozycja medyczna do zapobiegania przejściu na leczenie operacyjne łagodnego rozrostu gruczołu krokowego
US20100009949A1 (en) * 2006-03-24 2010-01-14 Bioxell S.P.A. Novel method
US8221803B1 (en) 2007-06-25 2012-07-17 OncoNatural Solutions, Inc. Composition for prostate health
US20120164240A1 (en) 2010-12-22 2012-06-28 Audino David Lawrence Enriched a. blitoides compositions and uses thereof
US20170049834A1 (en) * 2015-08-18 2017-02-23 Golden Biotechnology Corporation Benign prostatic hyperplasia add-on therapy
FR3063906B1 (fr) * 2017-03-20 2025-12-12 Pf Medicament Utilisation de l'oleoresine de copaifera dans les pathologies de la prostate
CN120960385A (zh) * 2025-08-01 2025-11-18 上海交通大学医学院附属第九人民医院 5α–还原酶降解分子及其制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5763429A (en) * 1993-09-10 1998-06-09 Bone Care International, Inc. Method of treating prostatic diseases using active vitamin D analogues
TW403735B (en) * 1995-11-22 2000-09-01 Hoffmann La Roche 25-hydroxy-16-ene-26, 27-bishomo-cholecalciferol
SG70009A1 (en) * 1996-05-23 2000-01-25 Hoffmann La Roche Vitamin d3 analogs
CA2289209C (en) * 1997-05-16 2006-07-25 Women & Infants Hospital Cyclic ether vitamin d3 compounds, 1.alpha. (oh) 3-epi-vitamin d3 compounds and uses thereof
US5872113A (en) * 1997-05-16 1999-02-16 Syntex (U.S.A.) Inc. Fluorinated vitamin D3 analogs
US6255501B1 (en) * 1999-04-26 2001-07-03 Hoffman-La Roche Inc. Process for preparing antiosteoporotic agents
WO2003034961A1 (en) * 2001-10-23 2003-05-01 Euro-Celtique, S.A. Terazosin transdermal device and methods
BR0214679A (pt) * 2001-12-03 2004-12-14 Novacea Inc Composições farmacêuticas compreendendo compostos a base de vitamina d ativa

Also Published As

Publication number Publication date
BE1016292A3 (nl) 2006-07-04
EA010240B1 (ru) 2008-06-30
EP1673096A1 (en) 2006-06-28
NZ535531A (en) 2006-03-31
NL1027109A1 (nl) 2005-03-29
BRPI0404050A (pt) 2005-06-14
WO2005027923A1 (en) 2005-03-31
CN100488511C (zh) 2009-05-20
NL1027109C2 (nl) 2005-05-03
CN1615891A (zh) 2005-05-18
FR2859910B1 (fr) 2006-04-28
EA200401100A1 (ru) 2005-04-28
JP2009035559A (ja) 2009-02-19
HK1085373A1 (zh) 2006-08-25
CH698144B1 (fr) 2009-05-29
FR2859910A1 (fr) 2005-03-25

Similar Documents

Publication Publication Date Title
Thiboutot et al. Update and future of hormonal therapy in acne
US20080207769A1 (en) Method for treating benign prostatic hyperplasia
JP2009035559A (ja) 良性前立腺肥大の治療のためのビタミンｄ３アナログの使用
DE602004002591T2 (de) Verwendung von zusammensetzungen enthaltend ein oestrogen zur behandlung und verhinderung von muskelskelettschmerzen
JPS62500451A (ja) ホルモン依存性がんの併用治療のための医薬組成物
TW201002330A (en) Compositions and methods for treating breast cancer
JP7046086B2 (ja) Ｍｐｃ阻害剤を使用する育毛を促進するための組成物及び方法
WO2003017973A1 (en) A method of treating benign gynaecological disorders and a drug delivery vehicle for use in such a method
IL278082B1 (en) Methods of treating heavy menstrual bleeding
JP6025301B2 (ja) 治療上の使用のためのｃ−１９ステロイド
KR20090119870A (ko) 자궁내막증 치료를 위한 미네랄코르티코이드 수용체 길항제
JP2003534278A (ja) 抗アンドロゲン作用および抗エストロゲン作用を提供するためのビカルタミド（ｂｉｃａｌｕｔａｍｉｄｅ）およびタモキシフェン（ｔａｍｏｘｉｆｅｎ）の併用医薬品
Watson et al. Hirsutism: evaluation and management
HK1085373B (en) Compound and use in the manufacture of a medicament for the treatment of benign prostatic hyperplasia and associated symptoms
JP2021519799A (ja) 物質離脱障害を治療するためのｇａｂａ−ａアンタゴニスト
CN101352446A (zh) 化合物及其在治疗良性前列腺增生及相关症状中的应用
GB2407499A (en) Compound and use in treatment
Rasmusson et al. Merck Research Laboratories, Rahway, NJ 07065
CN119894515A (zh) 用黄体生成素受体激动剂治疗肥胖症的方法
WO2022115581A1 (en) Methods for treating infertility and/or endometriosis comprising ex-527
Yahya Abdelrahman et al. Polycystic ovary syndrome in adolescents
Yapura Development of a non-steroidal aromatase inhibitor-based protocol for the control of ovarian function using a bovine model
Wang 8 ANDROGEN REPLACEMENT
TW201532613A (zh) 用於贅瘤（ｎｅｏｐｌａｓｉａ）治療之組合療法

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070907

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070907

A762 Written abandonment of application

Free format text: JAPANESE INTERMEDIATE CODE: A762

Effective date: 20100210